不同频次耳后注射甲强龙治疗突发性聋的疗效

The Effect of Different Injection Intervals of Retroauricular Injection of Methylprednisolone on the Treatment of Sudden Deafness

刘丹;张玉波;单春光;贾巧静;贾占伟;

1:河北医科大学第二医院耳鼻咽喉科

摘要
目的观察不同频次耳后注射甲强龙对突发性聋的疗效。方法选取2018年1~10月住院治疗的113例(113耳)突发性聋患者,按入院顺序分为三组:A组43例(43耳),B组38例(38耳),C组32例(32耳),分别耳后注射甲强龙40 mg隔一日一次、隔二日一次、隔三日一次,均共注射4次;同时每组均按照中华医学会耳鼻咽喉头颈外科学分会制定的突聋诊断和治疗指南建议的常规治疗方案,治疗2周后复查纯音听阈,比较三组疗效。结果 A、B、C三组的有效率分别为37.2%(16/43)、36.8%(14/38)、46.9%(15/32),三组有效率差异无统计学意义(P>0.05)。结论不同频次耳后注射甲强龙对突发性聋的有效率无显著影响。
关键词
注射频次;耳后注射;甲强龙;突发性聋;疗效
基金项目(Foundation):
河北省政府资助临床医学优秀人才和基础课题研究项目(361004)
作者
刘丹;张玉波;单春光;贾巧静;贾占伟;
参考文献

1 Stachler RJ,Chandrasekhar SS,Archer SM,et al.Clinical practice guide line :sudden hearing loss[J].Otolaryngol Head Neck Surgery,2012,146:S1.

2 Li J,Yu L,Xia R,et al.Postauricular hypodermic injection to treat inner ear disorders:experimental feasibility study using magnetic resonance imaging and pharmacokinetic comparison [J].Laryngolotol,2013,127:239.

3 李克兢,余力生,夏睿,等.磁共振成像观察耳后给药促进药物进入内耳的可行性[J].中华耳科学杂志,2012,10:144.

4 杨晓琦,余力生,马鑫.耳后注射复方倍他米松治疗顽固性低频型感音神经性聋[J].中华耳鼻咽喉头颈外科杂志,2007,42:814.

5 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.突发性聋诊断和治疗指南 [J].中华耳鼻咽喉头颈外科杂志,2015,50:443.

6 中国突发性聋多中心临床研究协作组.中国突发性聋分型治疗的多中心临床研究[J].中华耳鼻咽喉头颈外科志,2013,48:355.

7 Fauser C,Schratzenstaller B,Gloddek B.Sudden sensorineural hearing loss:does application of glucocorticoids make sense?[J] Arch Otolaryngol Head Neck Surg,2001,127:253.

8 Selivanova OA,Gouveris H,Victor A.Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss[J].Otol Neurotol,2005,26:890.

9 Stachler RJ,Chandrasekhar SS,Archer SM,et a1.American Academy of Otolaryngology—Head and Neck Surgery.Clinical practice guideline:sudden hearing loss[J].Otolaryngology—Head and Neck Surgery,2012,146:S1.

10 张武宁,唐安洲,徐志文.糖皮质激素治疗突发性耳聋的作用机制[J].医学综述,2013,19:2513.

11 余力生,主编.常见内耳疾病余力生2017观点[M].北京:科学技术文献出版社,2017.114~133.

12 石茭,韩琳,李晶兢,等.耳后给药及鼓室给药外淋巴液药物浓度的实验观察[J].中华耳科学杂志,2016,14:540.

13 刁桐湘,余力生,静媛媛,等.耳后注射异硫氰酸荧光素标记葡聚糖的可能转运途径[J].听力学及言语疾病杂志,2017,25:396.

14 林运娟,余力生.大鼠耳后和肌肉注射地塞米松后内耳组织药物浓度分析[J].中国耳鼻咽喉头颈外科,2009,16:381.

15 静媛媛,李兴启,余力生.耳后注射复方倍他米松豚鼠血浆中药代动力学特征[J].听力学及言语疾病杂志,2009,17:354.

16 李晶兢,余力生.7.0T磁共振成像观察耳后给药促进药物进入内耳的可行性[J].中华耳科学杂志,2012,10:144.

17 Su CM,Yun LH,Saeng CC,et al.Optimal dosage of menthylprednisolong for the treatment of sudden hearing loss ingeriatric patients:a propensity score matched analysis[J].PLosone,2014,9:e111479.

18 Czock D,Keller DF,Rasche FM,et al.Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids[J].Clinical pharmacokinetics,2005,44:61.

19 Antal EJ,Rd WC,Gillespie WR,et al.Influence of route of administration on the pharmacokinetics of methylprednisolone[J].Journal of Pharmacokinetics & Biopharmaceutics,1983,11:561.

20 宁光.糖皮质激素临床应用基本原则[J].中国实用内科杂志,2013,33:756.